HYS-11789-13718
1 vaccination
1 coded response
13 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 0-4
- ZIP prefix
- 101 / NY
- Registered
- 2022-07-15
- Relationship
- Child or adolescent in my care
- Guardian
- ABY-10564-39184
- Race
- N/A
- Ethnicity
- N/A
Timeline
-
2022-07-14
Dose 1 — Pfizer-BioNTech
-
2022-07-15
Registered in v-safe
- 2022-07-15
-
2022-07-16
Survey response — days 1–6 daily, dose 1, under 3MedDRA: Erythema — Feeling: Good · Site: RednessFree text: Redness is very slightMedDRA releases: 2024-11 · check-in free text available
- 2022-07-17
- 2022-07-19
- 2022-07-20
- 2022-07-23
- 2022-07-31
- 2022-08-04
- 2022-08-11
- 2022-08-18
- 2022-08-25
- 2022-10-13
- 2023-01-14
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-07-14 | Pfizer-BioNTech | No |
Free text
Release 12 (Under 3) — days 1–6 daily, dose 1, under 3
Systemic reaction (other): Redness is very slight
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Erythema | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release